|
Mr. Makar joined Bioject as President and Chief Executive Officer in October 2007. Prior to joining Bioject, Mr. Makar was Vice President and General Manager of the Therapeutics Business Unit at Berlex Labs, the U.S. Division of Schering AG. Mr. Makar is a graduate of Rutgers College of Pharmacy in Piscataway, New Jersey and holds a Masters degree in Business Administration from the Columbia University Graduate School of Business in New York City, New York. | 